• Die Fortschritte der Forschung sind die einzige Hoffnung der Patienten auf wirksame Therapien!

  • Unterstützen Sie die Forschung an seltenen genetischen Muskelkrankheiten!

Advanvces in skeletal muscle biology in health and disease

Gainesville, 6-8 march 2019

This conference is well suited for informal interactions and the presentation of data that might be too preliminary for a larger audience. Overall, the goal is to facilitate advances in skeletal muscle biology through discussions that promote new ideas, research lines, and collaborations.

Abstract submission: 10 January 2019

*****************************************************

ENMC Workshopsbericht

GNE myoptahy. 14-16 September 2018

Auf deutsch verfügbar

************************************************************

12th Swiss Meeting on Muscle Research

Magglingen, 4-6 November 2018

Congratulations to the 2018 winners of the Poster prize:

1st Prize: Marco Kaiser, Biozentrum, University of Basel
2nd Prize: Jan Eckhardt, University of Basel
3rd Prize: Jessica Brunetti, University of Geneva

*************************************************************************************

Grant opportunity on DM1 research

The Myotonic Dystrophy Foundation is pleased to announce a Request for Applications (RFA) for the Development of a Genome Editing Strategy for Myotonic Dystrophy Type 1. MDF intends to issue two 2-year awards of up to $250,000 total cost each for projects that address the evaluation of genome editing strategies for DM1 that target the DMPK gene.

More info

ORAI1 channel gating and selectivity is differentially altered by natural mutations in the first or third transmembrane domain.

Bulla M, Gyimesi G, Kim JH, Bhardwaj R, Hediger MA, Frieden M, Demaurex N.
J Physiol. 2018 Nov 1 [Epub ahead of print]

01 November 2018

Distinct patterns of skeletal muscle mitochondria fusion, fission and mitophagy upon duration of exercise training.

Arribat Y, Broskey NT, Greggio C, Boutant M, Conde Alonso S, Kulkarni SS, Lagarrigue S, Carnero EA, Besson C, Cantó C, Amati F.
Acta Physiol (Oxf). 2018 Aug 24:e13179.

02 September 2018

STAC3 variants cause a congenital myopathy with distinctive dysmorphic features and malignant hyperthermia susceptibility.

Zaharieva I, Sarkozy A, Munot P, Manzur A, et al.
Hum Mutat. 2018 Aug 31.

31 August 2018

Muscle Wasting Diseases: Novel Targets and Treatments.

Furrer R, Handschin C.
Annu Rev Pharmacol Toxicol. 2018 Aug 27

27 August 2018